Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-11-13
2007-11-13
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S269000, C514S274000, C514S318000, C544S238000, C544S317000, C544S328000, C544S329000, C546S193000, C546S194000
Reexamination Certificate
active
10496018
ABSTRACT:
Compounds of formula (I)in which R1, R2, R3and R4, have the meanings given in the specification are Factor Xa inhibitors useful in the treatment of thrombotic disorders.
REFERENCES:
patent: 6784182 (2004-08-01), Liebeschuetz et al.
patent: 6855715 (2005-02-01), Liebeschuetz et al.
patent: WO 99/11657 (1999-03-01), None
patent: WO 99/11658 (1999-03-01), None
patent: WO 00/76971 (2000-12-01), None
patent: WO 01/96304 (2001-12-01), None
Jones, Stuart D, et al., Bioorganic & Medicinal Chemistry Letters 11 (2001) 733-736.
Hiscock Steven Douglas
Jones Stuart Donald
Sall Daniel Jon
Wiley Michael Robert
Young Stephen Clinton
Dentz Bernard
Eli Lilly and Company
Jackson Thomas E.
LandOfFree
Chemical compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemical compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3844302